Cancer Therapy Reduces Lung Scarring

Scientists at the Stanford Institute for Stem Cell Biology and Regenerative Medicine have discovered a striking parallel between scar tissue formation and tumor growth: they both evade immune surveillance. As a result of this similarity, therapies to reactivate the immune system to target cancer cells have been shown to also work for treating scar tissue in the lung. The work was published recently in Nature Communications.